Advertisement

Newsroom

Benchmark acquires INVE Aquaculture

UK-based Benchmark Holdings plc has reached agreement to acquire INVE Aquaculture Holding B.V. (INVE), a leading international specialist manufacturer of primary stage technically advanced nutrition and health products for aquaculture, for a total consideration of $342 million (approximately £227 million).

December 18, 2015

Benchmark Holdings plc has reached agreement to acquire INVE Aquaculture Holding B.V. (INVE), a leading specialist manufacturer of primary stage technically advanced nutrition and health products for aquaculture, for a total consideration of $342 million (approximately £227 million).

Of the headline consideration, $300 million (approximately £199 million) will be payable in cash and $42 million (approximately £28 million) will be satisfied through the issue of Consideration Shares. Following the acquisition, which is expected to be earnings enhancing in the first full financial year post-completion, INVE management will join the Enlarged Group and invest in Benchmark shares.

Malcolm Pye, Chief Executive of Benchmark, commented: “The acquisition of INVE makes Benchmark a global leader in the aquaculture technology market overnight. Aquaculture is not only a multi-billion dollar sector but one of the fastest growing in the food industry. Importantly we believe the teams at Benchmark and INVE share a common ethos and culture. Both companies have a history of working collaboratively with partners to develop technologies, and both have a drive to address one of the most pressing issues of our time in developing a healthy, sustainable food chain.”

“Since listing, Benchmark has a proven track record of successfully integrating acquisitions – as with SalmoBreed and StofnFiskur last year – and this deal underpins our future growth ambitions. The potential opportunities and synergies presented by INVE offer a step-up both in terms of the technology applied in our products, and the marketing and distribution network already present in some of the fastest growing markets in the world.”

Philippe Léger, Chief Executive Officer of INVE, commented:  “Stimulating healthy growth and performance in aquaculture has always been INVE Aquaculture’s main driver. Becoming part of the Benchmark group will definitely reinforce this. This new milestone on our growth path unlocks INVE’s inherent potential to serve our customers globally with the industry’s most comprehensive portfolios of specialized aquaculture products.

Benchmark’s toolbox of health and genetics solutions will complete INVE’s current offering in advanced nutritional and health products. Together we will become a unique knowledge and solutions platform that supports our customers in taking better care throughout the culture lifecycle. As a result we can more effectively than ever contribute to our clients’ sustainable growth and long-term success.”

As INVE is a larger company than Benchmark, the deal is considered to be a reverse takeover and is subject to shareholder approval, which is expected to be completed by 30 December.

In 2014, INVE generated $89m in revenues with earnings of $25.4m.

Advertisement

Latest Magazine

Event news